In vitro study of novel collagenase (XIAFLEX®) on Dupuytren's disease fibroblasts displays unique drug related properties.
Dupuytren's disease (DD) is a benign, fibroproliferative disease of the palmar fascia, with excessive extracellular matrix (ECM) deposition and over-production of cytokines and growth factors, resulting in digital fixed flexion contractures limiting hand function and patient quality of life. Su...
Guardado en:
Autores principales: | Farhatullah Syed, Alexis N Thomas, Subir Singh, Venkatesh Kolluru, Susan G Emeigh Hart, Ardeshir Bayat |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/97f76caf62034bed873be8847ebc93aa |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Late complications of clinical clostridium histolyticum collagenase use in Dupuytren's disease.
por: Warren M Rozen, et al.
Publicado: (2012) -
Enfermedad de Dupuytren: revisión
por: Wagner,Pablo, et al.
Publicado: (2012) -
Immunotargeting of collagenase on thrombus
por: Yi-ling Lu, et al.
Publicado: (2010) -
Treatment of Dupuytren's Contracture at the Present Stage (Literature Review)
por: Ch. Z. Butaev, et al.
Publicado: (2019) -
Illuminating the effect of beneficial blue light and ROS-modulating enzymes in Dupuytren's disease.
por: Carina Jaekel, et al.
Publicado: (2021)